1. Home
  2. IMMP vs NEWP Comparison

IMMP vs NEWP Comparison

Compare IMMP & NEWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • NEWP
  • Stock Information
  • Founded
  • IMMP 1987
  • NEWP 1972
  • Country
  • IMMP Australia
  • NEWP Canada
  • Employees
  • IMMP N/A
  • NEWP N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • NEWP
  • Sector
  • IMMP Health Care
  • NEWP
  • Exchange
  • IMMP Nasdaq
  • NEWP Nasdaq
  • Market Cap
  • IMMP 304.0M
  • NEWP 262.4M
  • IPO Year
  • IMMP N/A
  • NEWP N/A
  • Fundamental
  • Price
  • IMMP $2.17
  • NEWP $1.27
  • Analyst Decision
  • IMMP Buy
  • NEWP Strong Buy
  • Analyst Count
  • IMMP 2
  • NEWP 1
  • Target Price
  • IMMP $8.50
  • NEWP $5.00
  • AVG Volume (30 Days)
  • IMMP 147.6K
  • NEWP 228.8K
  • Earning Date
  • IMMP 12-27-2024
  • NEWP 02-11-2025
  • Dividend Yield
  • IMMP N/A
  • NEWP N/A
  • EPS Growth
  • IMMP N/A
  • NEWP N/A
  • EPS
  • IMMP N/A
  • NEWP N/A
  • Revenue
  • IMMP $2,563,302.00
  • NEWP N/A
  • Revenue This Year
  • IMMP N/A
  • NEWP N/A
  • Revenue Next Year
  • IMMP $10.84
  • NEWP N/A
  • P/E Ratio
  • IMMP N/A
  • NEWP N/A
  • Revenue Growth
  • IMMP 9.59
  • NEWP N/A
  • 52 Week Low
  • IMMP $1.66
  • NEWP $0.87
  • 52 Week High
  • IMMP $3.34
  • NEWP $2.53
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 55.07
  • NEWP 31.26
  • Support Level
  • IMMP $2.00
  • NEWP $1.52
  • Resistance Level
  • IMMP $2.39
  • NEWP $1.60
  • Average True Range (ATR)
  • IMMP 0.13
  • NEWP 0.09
  • MACD
  • IMMP 0.01
  • NEWP -0.02
  • Stochastic Oscillator
  • IMMP 54.17
  • NEWP 4.55

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About NEWP New Pacific Metals Corp.

New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.

Share on Social Networks: